Source:http://linkedlifedata.com/resource/pubmed/id/20016943
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-4-13
|
pubmed:abstractText |
Chemokines function in the migration of circulating leukocytes to regions of inflammation, and have been implicated in chronic inflammatory conditions including mycobacterial infection. We investigated whether Leukotactin-1 (Lkn-1), a novel member of the CC-chemokines, is involved in the immune response of macrophages against Mycobacterium tuberculosis (MTB). In PMA-differentiated THP-1 cells, MTB infection increased mRNA expression of Lkn-1 in a dose-dependent manner. Lkn-1 induction peaked 12 h after infection, then declined gradually and returned to its basal level at 72 h. Secretion of Lkn-1 was elevated by MTB infection. The increase in expression and secretion of Lkn-1 caused by MTB was reduced in cells treated with inhibitors of phosphatidylinositol 3-kinase (PI3-K), 3-phosphoinositide-dependent kinase 1 (PDK1) and Akt. MTB-induced Akt phosphorylation was blocked by treatment with a PI3-K inhibitor or a PDK1 inhibitor, implying that PI3-K, PDK1, and Akt are associated with the signaling pathway that up-regulates Lkn-1 in response to MTB. These results suggest that Lkn-1 is novel member of the group of chemokines that is released by macrophages infected with MTB.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCL15 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC,
http://linkedlifedata.com/resource/pubmed/chemical/Macrophage Inflammatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Protein v-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/pyruvate dehydrogenase...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0219-1032
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20016943-Cell Line, Tumor,
pubmed-meshheading:20016943-Chemokines, CC,
pubmed-meshheading:20016943-Chemotaxis,
pubmed-meshheading:20016943-Humans,
pubmed-meshheading:20016943-Macrophage Inflammatory Proteins,
pubmed-meshheading:20016943-Macrophages,
pubmed-meshheading:20016943-Mycobacterium tuberculosis,
pubmed-meshheading:20016943-Oncogene Protein v-akt,
pubmed-meshheading:20016943-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:20016943-Protein Kinase Inhibitors,
pubmed-meshheading:20016943-Protein-Serine-Threonine Kinases,
pubmed-meshheading:20016943-Signal Transduction,
pubmed-meshheading:20016943-Tuberculosis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Mycobacterium tuberculosis-induced expression of Leukotactin-1 is mediated by the PI3-K/PDK1/Akt signaling pathway.
|
pubmed:affiliation |
Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, Wonju, 220-710, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|